Cargando…

Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS

Polycystic ovary syndrome (PCOS) is an endocrine/metabolic disorder associated with insulin resistance (IR) and obesity. Endometria from women with PCOS present failures in insulin action, glucose uptake and signaling of insulin-sensitizing molecules, such as adiponectin, with consequences for repro...

Descripción completa

Detalles Bibliográficos
Autores principales: Oróstica, Maria Lorena, Astorga, Isis, Plaza-Parrochia, Francisca, Poblete, Cristian, Carvajal, Rodrigo, García, Víctor, Romero, Carmen, Vega, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999908/
https://www.ncbi.nlm.nih.gov/pubmed/35409282
http://dx.doi.org/10.3390/ijms23073922
_version_ 1784685303809703936
author Oróstica, Maria Lorena
Astorga, Isis
Plaza-Parrochia, Francisca
Poblete, Cristian
Carvajal, Rodrigo
García, Víctor
Romero, Carmen
Vega, Margarita
author_facet Oróstica, Maria Lorena
Astorga, Isis
Plaza-Parrochia, Francisca
Poblete, Cristian
Carvajal, Rodrigo
García, Víctor
Romero, Carmen
Vega, Margarita
author_sort Oróstica, Maria Lorena
collection PubMed
description Polycystic ovary syndrome (PCOS) is an endocrine/metabolic disorder associated with insulin resistance (IR) and obesity. Endometria from women with PCOS present failures in insulin action, glucose uptake and signaling of insulin-sensitizing molecules, such as adiponectin, with consequences for reproduction. Metformin (MTF) treatment improves insulin signaling in endometrial tissues, but its mechanism is not fully understood. This study addresses the MTF effect, as well as adiponectin agonist action, on levels of molecules associated with insulin and adiponectin signaling pathways in endometrial tissue and cells, as assessed by immunohistochemistry and immunocytochemistry, respectively. Endometrial tissues were obtained from women and divided into five groups: Normal Weight (control); Obesity + IR; Obesity + IR + PCOS; Obesity + IR + MTF; Obesity + IR + PCOS + MTF. Endometrial cells stimulated with TNFα (as obesity-marker) were also used to partially emulate an obesity environment. The results showed low levels of insulin/adiponectin signaling in the endometria from women with obesity, IR and PCOS compared with the control group. MTF re-established these levels, independently of PCOS. TNFα-associated molecules were elevated in pathologic endometria, whereas MTF diminished these levels. The low levels of insulin/adiponectin molecules in endometrial cells treated with TNFα were reverted by MTF, similar to what was observed in the case of the adiponectin agonist. Therefore, independently of PCOS, MTF can re-establish levels of molecules involved in insulin/adiponectin signaling in endometrial cells, suggesting an improvement in insulin action and reproductive failures observed in endometria from women with obesity/PCOS.
format Online
Article
Text
id pubmed-8999908
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89999082022-04-12 Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS Oróstica, Maria Lorena Astorga, Isis Plaza-Parrochia, Francisca Poblete, Cristian Carvajal, Rodrigo García, Víctor Romero, Carmen Vega, Margarita Int J Mol Sci Article Polycystic ovary syndrome (PCOS) is an endocrine/metabolic disorder associated with insulin resistance (IR) and obesity. Endometria from women with PCOS present failures in insulin action, glucose uptake and signaling of insulin-sensitizing molecules, such as adiponectin, with consequences for reproduction. Metformin (MTF) treatment improves insulin signaling in endometrial tissues, but its mechanism is not fully understood. This study addresses the MTF effect, as well as adiponectin agonist action, on levels of molecules associated with insulin and adiponectin signaling pathways in endometrial tissue and cells, as assessed by immunohistochemistry and immunocytochemistry, respectively. Endometrial tissues were obtained from women and divided into five groups: Normal Weight (control); Obesity + IR; Obesity + IR + PCOS; Obesity + IR + MTF; Obesity + IR + PCOS + MTF. Endometrial cells stimulated with TNFα (as obesity-marker) were also used to partially emulate an obesity environment. The results showed low levels of insulin/adiponectin signaling in the endometria from women with obesity, IR and PCOS compared with the control group. MTF re-established these levels, independently of PCOS. TNFα-associated molecules were elevated in pathologic endometria, whereas MTF diminished these levels. The low levels of insulin/adiponectin molecules in endometrial cells treated with TNFα were reverted by MTF, similar to what was observed in the case of the adiponectin agonist. Therefore, independently of PCOS, MTF can re-establish levels of molecules involved in insulin/adiponectin signaling in endometrial cells, suggesting an improvement in insulin action and reproductive failures observed in endometria from women with obesity/PCOS. MDPI 2022-04-01 /pmc/articles/PMC8999908/ /pubmed/35409282 http://dx.doi.org/10.3390/ijms23073922 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Oróstica, Maria Lorena
Astorga, Isis
Plaza-Parrochia, Francisca
Poblete, Cristian
Carvajal, Rodrigo
García, Víctor
Romero, Carmen
Vega, Margarita
Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS
title Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS
title_full Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS
title_fullStr Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS
title_full_unstemmed Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS
title_short Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS
title_sort metformin treatment regulates the expression of molecules involved in adiponectin and insulin signaling pathways in endometria from women with obesity-associated insulin resistance and pcos
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999908/
https://www.ncbi.nlm.nih.gov/pubmed/35409282
http://dx.doi.org/10.3390/ijms23073922
work_keys_str_mv AT orosticamarialorena metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos
AT astorgaisis metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos
AT plazaparrochiafrancisca metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos
AT pobletecristian metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos
AT carvajalrodrigo metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos
AT garciavictor metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos
AT romerocarmen metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos
AT vegamargarita metformintreatmentregulatestheexpressionofmoleculesinvolvedinadiponectinandinsulinsignalingpathwaysinendometriafromwomenwithobesityassociatedinsulinresistanceandpcos